Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease

Authors :: L. Lee Hamm
Matthew R. Weir
Mahboob Rahman
Edgar R. Miller
Jing Chen
Chi-yuan Hsu
Dawei Xie
Jiang He
Dominic S. Raj
Panduranga Rao
Hsiang-Yu Chen
Joshua D. Bundy
Debbie L. Cohen
James P. Lash
George Thomas
Jackson T. Wright
Source :: Hypertension. 73:785-793
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.
Abstract: Apparent treatment-resistant hypertension (ATRH) is highly prevalent and associated with cardiovascular disease risk in patients with chronic kidney disease. We analyzed the association of inflammatory biomarkers with ATRH and its complications in patients with chronic kidney disease. ATRH was defined as blood pressure ≥140/90 mm Hg while taking ≥3 antihypertensive medications or blood pressure

Subjects :: 0301 basic medicine
medicine.medical_specialty
business.industry
Inflammation
030204 cardiovascular system & hematology
medicine.disease
Gastroenterology
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Internal medicine
Internal Medicine
medicine
Disease risk
In patient
medicine.symptom
business
Treatment resistant
Kidney disease

Tools